MSD
The 2027 Future Talent Program offers a 6-month co-op opportunity within the Research Division's Pharmaceutical Sciences and Clinical Supply organization. This role focuses on sterile and specialty product development, providing candidates with hands-on experience in formulation development for diverse pharmaceutical modalities. Participants will collaborate with experienced scientists to solve key challenges in drug delivery and process development.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Student Scientist Co-op
Secant Group
Scientist, Dissolution & Biopharmaceutical Modeling
Eli Lilly and Company
Formulation Development Co-op
C0003153479P
Scientist, Formulation Chemistry
Eurofins
2027 Summer Intern PhD Student - Drug Product Development Sterile Formulation
Bristol Myers Squibb
Synthetic Molecule Design and Development
Eli Lilly and Company